BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11336862)

  • 1. Midlife women making hormone therapy decisions.
    MacLaren A; Woods NF
    Womens Health Issues; 2001; 11(3):216-30. PubMed ID: 11336862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Women's decision making about the use of natural health products at menopause: a needs assessment and patient decision aid.
    Légaré F; Stacey D; Dodin S; O'Connor A; Richer M; Griffiths F; LeBlanc A; Rousseau JL; Tapp S
    J Altern Complement Med; 2007 Sep; 13(7):741-49. PubMed ID: 17931067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and opinions of hormone therapy prior to the Women's Health Initiative: a multinational survey on four continents.
    Heinemann K; Rübig A; Strothmann A; Nahum GG; Heinemann LA
    J Womens Health (Larchmt); 2008 Sep; 17(7):1151-66. PubMed ID: 18774896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lifestyle risk management--a qualitative analysis of women's descriptions of taking hormone therapy following surgically induced menopause.
    Crowe M; Burrell B; Whitehead L
    J Adv Nurs; 2012 Aug; 68(8):1814-23. PubMed ID: 22082259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Women's trust in and use of information sources in the treatment of menopausal symptoms.
    Huston SA; Jackowski RM; Kirking DM
    Womens Health Issues; 2009; 19(2):144-53. PubMed ID: 19272565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why women choose compounded bioidentical hormone therapy: lessons from a qualitative study of menopausal decision-making.
    Thompson JJ; Ritenbaugh C; Nichter M
    BMC Womens Health; 2017 Oct; 17(1):97. PubMed ID: 28969624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negotiating competing discourses: the decision to take menopausal hormone therapy following surgical menopause.
    Burrell B; Valledor V; Crowe M; Whitehead L
    Women Health; 2010 Sep; 50(6):527-43. PubMed ID: 20981635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long term impact of the WHI studies on information-seeking and decision-making in menopause symptoms management: a longitudinal analysis of questions to a medicines call centre.
    Natari RB; Hollingworth SA; Clavarino AM; Dingle KD; McGuire TM
    BMC Womens Health; 2021 Oct; 21(1):348. PubMed ID: 34607596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Women's health in midlife: the influence of the menopause, social factors and health in earlier life.
    Kuh DL; Wadsworth M; Hardy R
    Br J Obstet Gynaecol; 1997 Aug; 104(8):923-33. PubMed ID: 9255084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Women's attitudes to hormone replacement therapy in the aftermath of the Women's Health Initiative study.
    Sveinsdóttir H; Olafsson RF
    J Adv Nurs; 2006 Jun; 54(5):572-84. PubMed ID: 16722955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sharing decisions ... women and their doctors discuss midlife issues and HRT.
    Proctor J
    Healthplan; 1999; 40(2):65-6, 73-4. PubMed ID: 10537475
    [No Abstract]   [Full Text] [Related]  

  • 12. Behaviours and attitudes influencing treatment decisions for menopausal symptoms in five European countries.
    Constantine GD; Graham S; Clerinx C; Bernick BA; Krassan M; Mirkin S; Currie H
    Post Reprod Health; 2016 Sep; 22(3):112-22. PubMed ID: 26895640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current recommendations: what is the clinician to do?
    Manson JE
    Fertil Steril; 2014 Apr; 101(4):916-21. PubMed ID: 24680650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. US women desire greater professional guidance on hormone and alternative therapies for menopause symptom management.
    Ma J; Drieling R; Stafford RS
    Menopause; 2006; 13(3):506-16. PubMed ID: 16735949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives on counseling patients about menopausal hormone therapy: strategies in a complex data environment.
    Parish SJ; Nappi RE; Kingsberg S
    Menopause; 2018 Aug; 25(8):937-949. PubMed ID: 29509600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Women's decision making about the use of hormonal and nonhormonal remedies for the menopausal transition.
    Theroux R; Taylor K
    J Obstet Gynecol Neonatal Nurs; 2003; 32(6):712-23. PubMed ID: 14649591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menopausal experiences and hormone replacement therapy use among women with physical impairments.
    Becker H; Stuifbergen AK; Gordon D
    Womens Health Issues; 2002; 12(4):212-9. PubMed ID: 12093585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The medical management of menopause: a four-country comparison care in urban areas.
    Sievert LL; Saliba M; Reher D; Sahel A; Hoyer D; Deeb M; Obermeyer CM
    Maturitas; 2008 Jan; 59(1):7-21. PubMed ID: 18178044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitudes towards the menopause and hormone therapy over the turn of the century.
    Lindh-Astrand L; Brynhildsen J; Hoffmann M; Liffner S; Hammar M
    Maturitas; 2007 Jan; 56(1):12-20. PubMed ID: 16797891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menopause as a long-term risk to health: implications of general practitioner accounts of prevention for women's choice and decision-making.
    Murtagh MJ; Hepworth J
    Sociol Health Illn; 2003 Mar; 25(2):185-207. PubMed ID: 14498939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.